Skip to main content
Rapid Medical obtains $9M in funding round

A round of Series B financing brought in $9 million for Rapid Medical, an Israeli developer of neurovascular interventional devices. The money will be used for securing FDA approvals for the company's TIGERTRIEVER stentriever and its COMANECI aneurysm collar bridging device, as well as to market the devices in Europe.

Full Story: